Back to results
US 2013/0296392 A1Published application
Methods for the treatment of overactive bladder
AssigneeTheravida, Inc.
InventorsMehdi PABORJI, Roger S. FLUGEL, Kenneth L. DUCHIN
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of treating overactive bladder in a patient, the method comprising identifying a patient in need thereof; and administering to the patient a composition comprising tolterodine, or a pharmaceutically acceptable salt thereof, and pilocarpine, or a pharmaceutically acceptable salt thereof, wherein after the administration Cmax for tolterodine is between 1.0-8.0 ng/mL.
Claims22
A method of treating overactive bladder in a patient, the method comprising:
- identifying a patient in need thereof;
- and
- administering to the patient a composition comprising tolterodine, or a pharmaceutically acceptable salt thereof, and pilocarpine, or a pharmaceutically acceptable salt thereof,
- wherein after the administration:
- Tmax for tolterodine is between 0.5-2.0 hr;
- Tmax for pilocarpine is between 0.5-2.0 hr;
- and
- Tmax for 5-hydroxy methyl tolterodine is between 0.5-2.0 hr.
5 more elements
A method of treating overactive bladder in a patient, the method comprising:
- identifying a patient in need thereof;
- and
- administering to the patient a composition comprising tolterodine, or a pharmaceutically acceptable salt thereof, and pilocarpine, or a pharmaceutically acceptable salt thereof,
- wherein after the administration Tmax for tolterodine is between 0.5-2.0 hr.
1 more element
Dependencies are inferred from the claim text.